Molecular Diagnostics for Personalized Medicine

More Information:

  •  

       

    Getting started with PathoGenius®

  •  

       

    PathoGenius® offers DNA guided, personalized medicine for wound care.

  •  

     

    PathoGenius® offers specifically designed Rapid screening for ENT applications and comprehensive bacterial and fungal diagnostics.

  •  

     

    PathoGenius® extends rapid screen molecular diagnostics for ENT and respiratory viruses.

  •  

     

    PathoGenius® offers specifically designed Rapid screening for BV as well as comprehensive bacterial and fungal diagnostics persistent infections.

 

Bacterial Vaginitis and Yeast Infections

 

Vaginitis is an inflammation of the vagina, often associated with an infection. The three main types of vaginitis are bacterial vaginosis (BV), vaginal candidiasis, and trichomoniasis. Vaginal candidiasis is often referred to as a yeast infection since the infecting organism is fungal. Most often, Candida albicans is the pathogenic organism. However, there are a number of other fungi associated with human infections.  Trichomoniasis is a form of vaginitis caused by the sexually transmitted single celled protozoan, Trichomonas vaginalis. BV is the most prevalent lower genital tract infection in women of reproductive age throughout the world. Millions of women are affected annually with BV, which is strongly associated with several adverse health outcomes; including preterm labor and delivery, pelvic inflammatory disease, postpartum and postabortal endometritis, and increased susceptibility to infection with various other pathogens, including Neisseria gonorrhoeae, Trichomonas vaginalis, Chlamydia trachomatis, Candida, HPV, HSV-2, and HIV-1. Abnormal vaginal discharge is often the only symptom of BV, and many women are asymptomatic.

 

Most microbial species that reside in the vagina cannot be cultured. Thus, with the power of next generation sequencing technology, the taxonomic composition of the vaginal microbiota and its community structure is only now becoming more understood. BV is a polymicrobial syndrome, characterized by a shift in vaginal microbiota from a predominant population of Lactobacillus spp. to a population of anaerobes; such as, Gardnerella vaginalis, Morbiluncus spp., Prevotella spp., Mycoplasma hominis and Atopobium vaginae. However, these organisms are also found in subjects who do not suffer from BV in low numbers, and thus cannot be used as a specific marker for disease.

 

Clinical Evidence for Molecular Diagnostics

 

 

Menard, J-P., et al. "Self-collected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis." European journal of clinical microbiology & infectious diseases 31.4 (2012): 513-518.

 

Cartwright, Charles P., et al. "Development and Validation of a Semiquantitative, Multitarget PCR Assay for Diagnosis of Bacterial Vaginosis."Journal of clinical microbiology 50.7 (2012): 2321-2329.

 

Cruciani, Federica, et al. "Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota."Antimicrobial agents and chemotherapy 56.8 (2012): 4062-4070.

 

Fredricks, David N., Tina L. Fiedler, and Jeanne M. Marrazzo. "Molecular identification of bacteria associated with bacterial vaginosis." New England Journal of Medicine 353.18 (2005): 1899-1911.

 

Ferris, Michael J., et al. "Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment." Journal of clinical microbiology 45.3 (2007): 1016-1018.

 

Zozaya-Hinchliffe, Marcela, et al. "Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis." Journal of clinical microbiology 48.5 (2010): 1812-1819.

 

Oakley, Brian B., et al. "Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis." Applied and environmental microbiology 74.15 (2008): 4898-4909.

 

Ling, Zongxin, et al. "Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis." BMC genomics 11.1 (2010): 488.

 

Kogan, Scott C., Marie Doherty, and Jane Gitschier. "An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences." New England Journal of Medicine 317.16 (1987): 985-99.

 

A division of Southwest Regional PCR, LLC

Copyright © 2017. PathoGenius® Laboratories. All Rights Reserved.